J&J should make bedaquiline affordable for people with TB - STAT

J&J should make bedaquiline affordable for people with TB - STAT

Opinion: If J&J really wants to support nurses, it should make the TB drug bedaquiline affordable

By SASHA CUTTLER AND MARY MAGEE AND GUY VANDENBERG

ADOBE

Bedaquiline, an important treatment for tuberculosis, costs too much for most people. Johnson & Johnson could sell it for $1 a day and still turn a profit.

READ MORE